The US Food and Drug Administration is asking the drug industry for notifications on spikes in demand, even though they're not required, to help prevent supply problems.
To Prevent Shortages, US FDA Wants Notices From Drug Firms On Spikes In Demand
Demand-related shortages are a relatively new problem, but FDA maintains its tools can prevent or end them.
More from Supply Chain
More from HBW Insight
Final rule’s requirement that ACNU formulations also remain available as Rx generics could limit revenues for marketers of the nonprescription drugs while approvals of ACNU applications from studies with participants having drugs delivered to their homes may require marketers to limit distribution to direct-to-consumer without clearance for sales in retail stores.
Anti-aging skin care device marketer UVVU Inc. agreed to discontinue or modify a number of claims for its SolaWave 4-in-1 Skin Care Wand with Red Light Therapy, since statements were not substantiated by an in-home use study on which they relied, says the National Advertising Division.
A round-up of the latest European consumer health appointments: Maxwellia adds CFO and board member; Reckitt restructures operations; Barentz names CEO.